liver cancer

Simple dietary change may slow liver cancer in at-risk patients

by Andrew Smith, Rutgers University edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science Advances has found that low-protein […]

Simple dietary change may slow liver cancer in at-risk patients Read More »

Immunotherapy before surgery boosts survival for for liver cancer patients, clinical research finds

by National Taiwan University edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Upper figure: clinical trial design. Lower figure: how ICI therapy induces antitumor immunity in HCC. Credit: National Taiwan University Immune checkpoint inhibitor (ICI) therapy before surgery for hepatocellular carcinoma (HCC) may produce major pathological response in about one-third

Immunotherapy before surgery boosts survival for for liver cancer patients, clinical research finds Read More »

Simple blood test formula identifies patients at high risk of liver cancer

by National Taiwan University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes The Steatosis-Associated Fibrosis Estimator (SAFE) score successfully stratifies patients at risk of developing hepatocellular carcinoma (HCC), regardless of their underlying liver conditions, such as viral hepatitis, alcoholic liver disease and metabolic dysfunction associated liver disease. Credit: Clinical and Molecular Hepatology A new scoring system using

Simple blood test formula identifies patients at high risk of liver cancer Read More »

Gut bacterium may sabotage liver cancer immunotherapy, study suggests

by The University of Hong Kong edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes Credit: Cell Reports Medicine (2025). DOI: 10.1016/j.xcrm.2025.102370 A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing to the failure

Gut bacterium may sabotage liver cancer immunotherapy, study suggests Read More »

Common heart medication shows promise against liver cancer

by University of Mississippi edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes Credit: Pixabay/CC0 Public Domain Liver cancer is the third-leading cause of cancer deaths worldwide, but a new study shows the solution to targeting this difficult-to-treat disease may already exist. Yatendra Singh, a postdoctoral researcher in the University of Mississippi Department of Biology, found that

Common heart medication shows promise against liver cancer Read More »

Cholesterol medication shows potential as a novel treatment for liver cancer

by The University of Hong Kong edited by Sadie Harley, reviewed by Robert Egan Credit: Pixabay/CC0 Public Domain A research team from the Department of Pathology at the University of Hong Kong’s LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could become a powerful new weapon in the fight against liver cancer.

Cholesterol medication shows potential as a novel treatment for liver cancer Read More »

Targeted therapy overcomes cell plasticity in liver cancer mouse models

by The University of Hong Kong edited by Lisa Lock, reviewed by Robert Egan Credit: The University of Hong Kong Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape for hepatocellular carcinoma (HCC), the most common type

Targeted therapy overcomes cell plasticity in liver cancer mouse models Read More »

McMaster research offers promising new treatment for liver cancer

Peer-Reviewed Publication McMaster University Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with Espervita Therapeutics have developed a promising new treatment that helps the immune system attack and destroy these tumours. The discovery, detailed

McMaster research offers promising new treatment for liver cancer Read More »

Study identifies ways to lower risk of liver cancer for people with hepatitis B infection

Peer-Reviewed Publication Mass General Brigham   FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Interleukin 33 (brown) upregulation in hepatitis B virus-positive chronic hepatitis. view more  Credit: Shawn Demehri, Mass General Brigham Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why they are connected remains unknown. Researchers from Mass General

Study identifies ways to lower risk of liver cancer for people with hepatitis B infection Read More »

How a rogue gene fuels liver cancer by disrupting fat metabolism

by The University of Hong Kong edited by Lisa Lock, reviewed by Robert Egan   Mechanism of how genetic player VPS72 impacts liver cancer. Too much VPS72 in cells activates the cancer-promoting pathway, which increases fat production and helps liver cancer grow. Credit: Advanced Science (2025). DOI: 10.1002/advs.202411368 Liver cancer is a lethal disease with limited treatment options for advanced

How a rogue gene fuels liver cancer by disrupting fat metabolism Read More »

Scroll to Top